title: Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.
abstract: Protease-activated receptors 1 and 4 (PAR1 and PAR4) mediate thrombin signaling in human platelets. Whether these receptors are redundant, interact, or serve only partially overlapping functions is unknown. We report that PAR1 and PAR4 signal with distinct tempos. In transfected fibroblasts, PAR4 triggered substantially more phosphoinositide hydrolysis per activated receptor than PAR1 and was shut off more slowly than PAR1. Shutoff and internalization of PAR1 depends upon phosphorylation of its carboxyl tail upon receptor activation. In contrast to PAR1, phosphorylation of PAR4 was undetectable, and activation-dependent internalization of PAR4 was much slower than that seen for PAR1. Mutation of potential phosphorylation sites in the carboxyl tail of PAR1 enhanced PAR1 signaling, whereas analogous mutations in PAR4 had no effect. Thus PAR4 signaling is shut off less rapidly than PAR1, probably due to differences in receptor phosphorylation. PAR1 and PAR4 also signaled with distinct tempos in platelets. PAR1 triggered a rapid and transient increase in intracellular calcium, whereas PAR4 triggered a more prolonged response. Together, the tempo of these responses accounted for that triggered by thrombin. Thus differences in the rates at which PAR1 and PAR4 are shut off allow thrombin to trigger intracellular signaling with distinct temporal characteristics.
authors.affiliation: Cardiovascular Research Institute, Daiichi Research Center, and Department of Medicine, University of California, San Francisco 94143-0130, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Shapiro
authors.forename: E J
authors.initials: EJ
authors.lastname: Weiss
authors.forename: T R
authors.initials: TR
authors.lastname: Faruqi
authors.forename: S R
authors.initials: SR
authors.lastname: Coughlin
mesh_terms: D000818:Animals; D000991:Antithrombins / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism; D019556:COS Cells; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D018076:DNA, Complementary / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis; D007700:Kinetics; D008094:Lithium / Q000494:pharmacology; D016296:Mutagenesis; D010455:Peptides / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D044463:Receptor, PAR-1; D018179:Receptors, Thrombin / Q000378:metabolism*; D015398:Signal Transduction; D013917:Thrombin / Q000378:metabolism* / Q000502:physiology; D013997:Time Factors; D014162:Transfection
chemical_list: D000991:Antithrombins; D018076:DNA, Complementary; D006629:Hirudins; D010455:Peptides; D010716:Phosphatidylinositols; D044463:Receptor, PAR-1; D018179:Receptors, Thrombin; D008094:Lithium; D013917:Thrombin; C112908:protease-activated receptor 4; D002118:Calcium